XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 92,057 $ 79,790
Marketable investments (Note 4) 52,395 54,333
Accounts receivable, net 38,552 70,023
Deferred commissions 10,884 13,731
Prepaid expenses and other current assets 13,292 18,942
Total current assets 207,180 236,819
Property and equipment, net 22,403 25,249
Goodwill 85,126 76,169
Intangible assets, net 5,368 732
Other assets 8,417 6,231
Total assets 328,494 345,200
Current Liabilities:    
Accounts payable 512 217
Accrued expenses and other current liabilities 41,364 49,629
Deferred revenue 128,435 145,207
Total current liabilities 170,311 195,053
Non-current liabilities 11,353 8,958
Total liabilities 181,664 204,011
Stockholders' Equity (Note 9):    
Preferred stock, $0.01 par value Authorized - 500 shares; issued and outstanding - none
Common stock, $0.01 par value Authorized - 125,000 shares Issued - 22,893 and 22,432 shares as of September 30, 2018 and December 31, 2017, respectively Outstanding - 18,262 and 18,041 shares as of September 30, 2018 and December 31, 2017, respectively 229 224
Additional paid-in capital 196,803 181,910
Retained earnings 126,006 123,010
Treasury stock - 4,631 and 4,391 shares as of September 30, 2018 and December 31, 2017, respectively, at cost (171,889) (161,943)
Accumulated other comprehensive loss (4,319) (2,012)
Total stockholders’ equity 146,830 141,189
Total liabilities and stockholders’ equity $ 328,494 $ 345,200